V8 Peptides — Engineered Performance
Research Library
TB-500 Reconstitution and Storage Guide
TB-500ReconstitutionStorage

TB-500 Reconstitution and Storage Guide

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

How should TB-500 be reconstituted and stored for laboratory work? Hold the sealed lyophilized vial at 2–8 °C, or at −20 °C when it will not be opened soon, and shield it from heat, moisture and light. Warm a cold vial to room temperature before piercing it, let a water-based diluent run down the inside of the glass, and rotate the vial slowly until the solution is clear. Pick bacteriostatic water for a vial that will be entered more than once and sterile water for stock that is split and frozen immediately. Keep solutions cold, thaw each frozen aliquot a single time, and label every container with lot, diluent, concentration and date.

TB-500 as listed here is a seven-residue, N-terminally acetylated peptide, not the 43-residue parent protein thymosin β4. That distinction drives almost every handling decision. A short, hydrophilic heptapeptide with a capped N-terminus behaves very differently in a vial from a longer chain that carries a methionine, and precautions borrowed from the parent molecule do not all transfer. The sections below cover the dry vial, diluent reasoning, storage tiers, freeze–thaw practice, inspection and documentation. The material is sold for laboratory research use only and is not for human or animal consumption.

The vial on arrival: lyophilized TB-500

The TB-500 research vial is listed as 10 mg of lyophilized powder with a purity specification of ≥98% by HPLC, in a sealed clear glass vial. The listed identity is Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, the acetylated 17–23 fragment of thymosin β4, with molecular formula C38H68N10O14 and a mass of about 889 Da. How a frozen solution becomes a dry solid is explained in what is lyophilization.

Ten milligrams of a small peptide with no bulking agent is very little solid. Expect a thin white layer or a wispy, cotton-like deposit, sometimes partly on the wall or under the stopper, not a deep cake. A vial that looks nearly empty is the usual case for this fill, and a deposit that shifted during transit has not lost mass.

Listed propertyValueWhy it matters at the bench
Vial size10 mgBasis for concentration arithmetic
Purity specification≥98% by HPLCCheck against the certificate figure, where published
SequenceAc-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ)Confirms the vial holds the fragment, not full-length thymosin β4
Molecular formulaC38H68N10O14Used for molar conversions and identity checks
Approximate massAbout 889 DaSmall molecule by peptide standards; fast to dissolve
Supplied formLyophilized powderDry state is the most stable state
ContainerSealed clear glass vialNo built-in light barrier; store boxed
Storage lineRefrigerate at 2–8 °C; −20 °C for long-term; protect from heat, moisture and lightSets the dry-storage tiers

Match the lot number to the COA library before opening. Where a certificate is published, it reports HPLC purity and sequence identity for that lot, and how to read a COA explains the layout. Compound background is in the TB-500 research overview, and the relationship to the parent protein is set out in TB-500 vs thymosin β4.

How the Ac-LKKTETQ sequence affects handling

  • No methionine in the fragment. Full-length thymosin β4 contains a methionine near its N-terminus that oxidizes to the sulfoxide, and general handling advice for the parent protein reflects that. The listed heptapeptide has no methionine, no cysteine and no tryptophan. Oxidation is therefore not the leading degradation route for this vial, although limiting warm, aerated storage remains sound general practice.
  • Acetylated N-terminus. The acetyl cap removes the free α-amino group. That eliminates one positive charge and closes off N-terminal reactions that affect uncapped peptides. It also means the acetyl group is part of the identity: a des-acetyl species is an impurity, distinguishable by mass and retention time.
  • C-terminal glutamine and an internal glutamate. Glutamine can deamidate to glutamic acid. The reaction is generally much slower than asparagine deamidation, but it is favoured by elevated pH and temperature, which argues for cold, near-neutral or mildly acidic storage and against keeping stock in alkaline buffers.
  • Two lysines. The Lys-Lys pair gives the peptide strongly basic side chains. Positively charged groups are a known driver of adsorption to glass and some plastics, a loss that becomes proportionally large in dilute solutions.
  • Balanced overall charge. Two lysines against one glutamate and the C-terminal carboxyl leave the capped peptide close to neutral overall, yet densely charged and hydrophilic. There is no hydrophobic stretch to drive aggregation, and water solubility is high.
  • No aromatic residue. Without tryptophan, tyrosine or phenylalanine there is no useful absorbance at 280 nm. Spectrophotometric concentration estimates do not work; chromatographic detection relies on the peptide bond at low UV wavelengths.
  • Counter-ion. The lysine side chains are isolated with a counter-ion, typically acetate or trifluoroacetate. The listing does not specify which. Residual trifluoroacetate can influence cultured cells, so read the salt form from the certificate before designing sensitive cell assays.

Choosing a diluent: reasoning for TB-500

Solubility is not the constraint. The decision turns on how the solution will be used after it is made.

DiluentAppropriate whenAdvantageDrawback
Bacteriostatic water (0.9% benzyl alcohol)One vial will be sampled repeatedlyPreservative holds back organisms introduced through the stopperBenzyl alcohol can affect migration and viability read-outs; include a vehicle control
Sterile waterStock is aliquoted and frozen at onceAdditive-free; simplest for cell culture and chromatographyUnpreserved; not for extended multi-entry refrigerated use
Buffered salineWorking dilutions at the time of the experimentMatches assay pH and ionic strengthPhosphate buffers shift pH on freezing; avoid for frozen stock
Organic co-solventNot requiredNone for a peptide this hydrophilicAdds an unnecessary variable and a second vehicle control

Cell-migration and tube-formation assays, which are common contexts for this peptide in vitro, are sensitive to small solvent effects, so the vehicle-control note in the first row is more than a formality. The preserved-versus-unpreserved question is covered in depth in bacteriostatic water explained. No fill volumes are given on this page; use the reconstitution calculator to turn vial mass and chosen volume into a concentration.

Reconstitution technique

The universal procedure is laid out in how to reconstitute a lyophilized peptide. For this vial, attention goes to three things: moisture, the thin deposit, and gentle mixing.

  1. Bring the sealed vial to room temperature. Opening it cold condenses water vapour onto a hygroscopic, lysine-rich solid.
  2. Locate the solid. With so little material, some may be on the shoulder or stopper. Tap it down and plan to rinse the wall with the incoming diluent.
  3. Swab and dry the stoppers. Let the alcohol flash off fully.
  4. Deliver the diluent slowly along the glass. Rotate the vial as the liquid enters so the whole inner surface is wetted.
  5. Rotate, rest, rotate. The peptide normally dissolves within a minute or two. Shaking is unnecessary and creates foam that holds peptide out of the bulk liquid.
  6. Inspect and label immediately.

Temperature tiers for dry and dissolved TB-500

Only the first two rows come directly from the product listing. The solution rows describe general laboratory convention for short peptides and should not be read as measured shelf lives for a given lot.

MaterialTierPurposeComment
Sealed lyophilized vial−20 °CLong-term holdingDark, dry, steady temperature
Sealed lyophilized vial2–8 °CVials queued for near-term useBoxed; away from the refrigerator door
Sealed lyophilized vialAmbientTransitTransfer to cold storage when received
Solution in bacteriostatic water2–8 °CMulti-entry working stockConventional discard point for preserved multi-use containers is about four weeks
Solution in sterile water2–8 °CShort holding onlyFreeze as aliquots instead of keeping it liquid
Single-use aliquots−20 °C or colderLong protocolsThaw once
Working dilution in buffer or mediumBench or incubatorImmediate useDo not keep leftovers

See storing research peptides for freezer and refrigerator practice across an inventory, and how long reconstituted peptides last for the reasoning behind the solution conventions.

Freeze–thaw behaviour and aliquots

During freezing, pure water crystallizes first and everything else, peptide, counter-ion and buffer salts, is concentrated into the unfrozen remainder. Local pH and ionic strength in that remainder can differ sharply from the starting solution, and the peptide is exposed to a large ice surface. A small, unstructured heptapeptide has no fold to lose, so the concern is chemical and physical: pH excursions that favour glutamine deamidation, and repeated wetting and re-wetting of container surfaces that the lysines readily bind.

The remedy is procedural. Divide fresh stock into single-session portions in low-binding tubes, freeze them in one batch, and remove only what a session needs. Thaw cold, invert gently to remix the stratified solution, and discard any excess. Mark a tube if it is ever thawed twice and record that in the notebook so the data can be interpreted accordingly.

Light, humidity and loss to surfaces

Humidity. Lysine-containing peptide salts take up water readily. Absorbed moisture mobilizes the solid and accelerates hydrolytic reactions, including deamidation. An intact crimp, cold dry storage and warming before opening are the controls.

Light. The sequence lacks the aromatic and sulfur side chains that make peptides photosensitive, so light is a lesser hazard here than for many other compounds. The listing still specifies protection from light; keeping vials boxed satisfies it and prevents warming under bench lamps.

Adsorption. This is the handling issue most easily overlooked with TB-500. Cationic side chains bind to negatively charged glass, and studies of peptide recovery from labware show that losses vary widely with the surface and worsen as concentration falls. Keep stock concentrated, prepare dilute working solutions immediately before use, prefer low-binding polypropylene, and do not move a dilute solution through more containers than necessary.

Visual QC checks

  • Before opening: white to off-white solid, however sparse; intact seal; no moisture droplets or yellowing.
  • After reconstitution: a clear, colorless liquid with no visible particles once bubbles have cleared.
  • Each later use: hold the vial against dark and light backgrounds. Cloudiness, strands, sediment or color means disposal.
  • After a thaw: refractive swirls that disappear on mixing are expected; persistent particles are not.

Because this peptide dissolves so readily, haze points toward contamination or a diluent problem far more often than toward incomplete dissolution; see cloudy peptide vial after reconstitution. Clarity is necessary but not sufficient. Deamidated or des-acetyl species are invisible to the eye and require chromatography, as discussed in TB-500 purity testing.

Record-keeping and labels

Good records turn a vial into a traceable reagent. At minimum, log:

  • Compound, listed sequence, vial size and lot number, with the certificate attached where one is published
  • Receipt date and dry-storage tier
  • Diluent type, diluent lot and expiry, and volume added
  • Resulting concentration and the calculation or calculator output behind it
  • Reconstitution date, operator, and first-puncture date for multi-entry vials
  • Aliquot count, volume, tube type and freezer position
  • Thaw events, inspection outcomes and disposal date

Write compound, concentration, lot and date directly on each vial and tube with a freezer-safe marker or label. Recording the sequence matters for this compound in particular, because the name TB-500 is applied in the literature and in commerce to both the fragment and the full-length protein. Sourcing documentation is discussed in where to buy TB-500.

What not to do

  • Do not assume the vial is under-filled because the deposit is small.
  • Do not shake or vortex.
  • Do not store stock in alkaline buffer, phosphate buffer or culture medium.
  • Do not keep sterile-water solutions refrigerated for extended periods.
  • Do not refreeze thawed aliquots or cycle a multi-entry vial through the freezer.
  • Do not prepare very dilute solutions in advance or store them in ordinary glass.
  • Do not try to quantify the peptide at 280 nm.
  • Do not apply molar conversions for full-length thymosin β4 to the heptapeptide; the masses differ several-fold.
  • Do not pierce a stopper that has not been disinfected and allowed to dry.

Stability data: what is published and what is not

The analytical literature on this fragment is real but narrow. The acetylated 17–23 peptide has been synthesized and characterized by liquid chromatography and mass spectrometry in the context of identifying it in commercial products, and the biology of short thymosin β4 sequences has been reviewed. Those papers establish identity and analytical behaviour. They are not shelf-life studies.

A peer-reviewed study following reconstituted Ac-LKKTETQ in bacteriostatic or sterile water over weeks at refrigerator and freezer temperatures, with a stability-indicating assay, does not appear to exist in the open literature. No half-life or percentage-remaining figure is offered here for that reason. The tiers in this guide derive from the storage line on the listing, from established peptide degradation chemistry, and from general conventions for preserved multi-entry containers. Where potency over time is critical to an experiment, verify the stock chromatographically or shorten the interval between reconstitution and use.

Summary

The listed TB-500 is a small, hydrophilic, N-acetylated heptapeptide with no methionine, cysteine or aromatic residue. It dissolves easily and is not prone to oxidation or aggregation; its realistic risks are moisture uptake by the dry solid, slow deamidation of glutamine under warm or alkaline conditions, microbial growth in unpreserved solutions, and adsorption of its lysine side chains to labware at low concentration. Store it cold, dark and dry, match the diluent to the use pattern, aliquot once, inspect every time, and document the sequence along with the lot.

Frequently asked questions

Why does a 10 mg TB-500 vial look almost empty?

Ten milligrams of a small peptide lyophilized without a bulking agent forms only a thin white layer or wispy deposit. The appearance reflects the fill, not a shortfall, and material that has shifted onto the wall or stopper is still part of the listed mass.

Which diluent is appropriate for TB-500 in laboratory research?

Bacteriostatic water is used when a vial will be entered repeatedly, because its benzyl alcohol preservative limits microbial growth. Sterile water is used when the stock is aliquoted and frozen immediately or when the assay cannot tolerate benzyl alcohol.

What storage temperature does the product listing give?

Refrigerate at 2–8 °C, use −20 °C for long-term storage, and protect the vial from heat, moisture and light.

Does TB-500 contain methionine that can oxidize?

The listed sequence, Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, contains no methionine, cysteine or tryptophan. Full-length thymosin β4 does contain methionine, which is why oxidation is often mentioned for the parent protein.

What does the N-terminal acetyl group change for handling?

It removes the free N-terminal amine, which lowers the positive charge by one and blocks N-terminal side reactions. A peptide missing the acetyl group is an impurity that chromatography and mass analysis can distinguish.

How long does reconstituted TB-500 remain stable?

No peer-reviewed stability study of the reconstituted heptapeptide appears to be published, so no exact figure can be stated. Laboratories typically follow the general convention of about four weeks for preserved multi-entry solutions under refrigeration and use frozen single-use aliquots for longer protocols.

Can a TB-500 solution be frozen and thawed repeatedly?

It is better not to. Each cycle exposes the peptide to concentrated, pH-shifted conditions and to container surfaces. Prepare single-session aliquots and thaw each one once.

Why is adsorption a concern for this peptide?

The two lysine side chains are positively charged and bind to negatively charged glass and some plastics. The proportion lost rises as solutions become more dilute, so keep stock concentrated and use low-binding tubes.

What does a properly reconstituted solution look like?

Clear and colorless, with no particles once bubbles have risen. Cloudiness, strands, sediment or any tint indicates the solution should be discarded.

Is TB-500 the same molecule as thymosin β4?

Not as listed here. The product is the acetylated 17–23 fragment of thymosin β4, about 889 Da, whereas the parent protein has 43 residues. Molar calculations and handling assumptions for one should not be applied to the other.

Where can the concentration be calculated?

Use the reconstitution calculator on the site with the vial mass and chosen diluent volume. This guide gives no fill volumes by design.

References

  1. Esposito S, Deventer K, Goeman J, Van der Eycken J, Van Eenoo P. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal. 2012;4(9):733-738. doi:10.1002/dta.1402
  2. Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J. 2010;24(7):2144-2151. doi:10.1096/fj.09-142307
  3. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51. doi:10.1517/14712598.2012.634793
  4. Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
  5. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
  6. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
  7. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. doi:10.1016/S0378-5173(00)00423-3
  8. Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.